{"id":34058,"date":"2014-10-15T10:42:02","date_gmt":"2014-10-15T14:42:02","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=34058"},"modified":"2014-10-15T10:42:02","modified_gmt":"2014-10-15T14:42:02","slug":"medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058","title":{"rendered":"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/15\/2014 (wallstreetpr) \u2013 On Tuesday, <strong>Medtronic, Inc. (NYSE:MDT)<\/strong> announced that it has initiated a pivotal study for the treatment of diabetes with its breakthrough technology, called the Predictive Low Glucose Management (PLGM).<\/p>\n<p style=\"text-align: justify;\">Medtronic posted an <a href=\"http:\/\/newsroom.medtronic.com\/phoenix.zhtml?c=251324&amp;p=irol-newsArticle&amp;id=1977362\" target=\"_blank\">article<\/a> in its newsroom that informed that\u00a0Medtronic, Inc. (NYSE:MDT) has enrolled the first set of patients in its investigational device exemption (IDE) research on the PLGM technology. The step is a significant advancement towards developing an artificial pancreas in the U.S.<\/p>\n<p style=\"text-align: justify;\"><strong>Chief Objectives<\/strong><\/p>\n<p style=\"text-align: justify;\">According to the announcement, the trial aims at evaluating the safety of Medtronic, Inc. (NYSE:MDT)\u2019s next-generation integrated insulin pump with its continuous glucose monitoring (CGM) system. The CGM system is s designed as to inhibit insulin delivery automatically when a predefined level of glucose is predicted to attain the lowest limit of tolerance. This is done using a sensor that measures the glucose levels. As the desired limit is reached, the system again automatically resumes delivery of insulin. Medtronic seeks to help diabetic patients to manage the problems related to the traditional insulin therapies for hypoglycemia and hyperglycemia. The two conditions, respectively, cause low and high sugar levels in diabetic patients&#8217; blood.<\/p>\n<p style=\"text-align: justify;\">The primary aim of this study is to assess the safety of the PLGM work-flow pattern using the new sensor. It will also evaluate the system\u2019s capability to prevent hypoglycemia, which occurs quite commonly and is a major concern in the management of the disease. The condition of hypoglycemia poses a threat of causing unresponsiveness and confusion. In extreme cases, hypoglycemia an also result into death of the patient.<\/p>\n<p style=\"text-align: justify;\">Medtronic, Inc. (NYSE:MDT)\u2019s study will evaluate the efficacy of the system on as many as 84 patients, who are enrolled at around eight facilities across the U.S. The study deploys a fourth-generation sensor along with latest intelligent sensor diagnostic equipment. The new diagnostics are 80% smaller as compared to the Enlite sensor that is currently used in the country. In addition, the study also uses a new MiniMed design of insulin pump.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/15\/2014 (wallstreetpr) \u2013 On Tuesday, Medtronic, Inc. (NYSE:MDT) announced that it has initiated a pivotal study for the treatment of diabetes with its [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":15691,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[3021,1022],"stock_ticker":[],"class_list":["post-34058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-medtronic-inc-nysemdt","tag-nysemdt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/15\/2014 (wallstreetpr) \u2013 On Tuesday, Medtronic, Inc. (NYSE:MDT) announced that it has initiated a pivotal study for the treatment of diabetes with its [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-15T14:42:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"599\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology\",\"datePublished\":\"2014-10-15T14:42:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\"},\"wordCount\":354,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg\",\"keywords\":[\"Medtronic Inc (NYSE:MDT)\",\"NYSE:MDT\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\",\"name\":\"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg\",\"datePublished\":\"2014-10-15T14:42:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg\",\"width\":1024,\"height\":599},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058","og_locale":"en_US","og_type":"article","og_title":"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology - Wall Street PR","og_description":"Boston, MA 10\/15\/2014 (wallstreetpr) \u2013 On Tuesday, Medtronic, Inc. (NYSE:MDT) announced that it has initiated a pivotal study for the treatment of diabetes with its [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-15T14:42:02+00:00","og_image":[{"width":1024,"height":599,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology","datePublished":"2014-10-15T14:42:02+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058"},"wordCount":354,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg","keywords":["Medtronic Inc (NYSE:MDT)","NYSE:MDT"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058","url":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058","name":"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg","datePublished":"2014-10-15T14:42:02+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Medtronic-Inc.jpg","width":1024,"height":599},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/medtronic-inc-nysemdt-enrolls-diabetic-patients-in-study-using-predictive-low-glucose-management-technology-34058#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Medtronic, Inc. (NYSE:MDT) Enrolls Diabetic Patients In Study Using Predictive Low Glucose Management Technology"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/34058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=34058"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/34058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/15691"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=34058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=34058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=34058"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=34058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}